Log in

NYSE:CHE - Chemed Stock Price, Forecast & News

$430.09
-5.83 (-1.34 %)
(As of 12/10/2019 08:24 AM ET)
Today's Range
$428.74
Now: $430.09
$436.19
50-Day Range
$394.63
MA: $417.27
$435.92
52-Week Range
$260.03
Now: $430.09
$441.79
Volume110,907 shs
Average Volume90,924 shs
Market Capitalization$6.89 billion
P/E Ratio36.05
Dividend Yield0.29%
Beta1.11
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.78 billion
Cash Flow$14.79 per share
Book Value$36.93 per share

Profitability

Net Income$205.54 million

Miscellaneous

Employees15,707
Market Cap$6.89 billion
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.


Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, November 1st. Investors of record on Monday, November 11th will be given a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, November 7th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has authorized a stock repurchase plan on Wednesday, March 7th 2018, which permits the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its shares are undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its earnings results on Tuesday, October, 29th. The company reported $3.46 EPS for the quarter, topping analysts' consensus estimates of $3.31 by $0.15. The company had revenue of $480.61 million for the quarter, compared to analyst estimates of $478.89 million. Chemed had a net margin of 11.14% and a return on equity of 35.06%. The business's quarterly revenue was up 8.2% compared to the same quarter last year. During the same period last year, the firm posted $3.07 EPS. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Chemed.

What price target have analysts set for CHE?

4 analysts have issued twelve-month price targets for Chemed's shares. Their forecasts range from $405.00 to $500.00. On average, they expect Chemed's stock price to reach $466.25 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price. View Analyst Price Targets for Chemed.

What is the consensus analysts' recommendation for Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Has Chemed been receiving favorable news coverage?

News coverage about CHE stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Chemed earned a daily sentiment score of 1.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Chemed.

Are investors shorting Chemed?

Chemed saw a decrease in short interest during the month of November. As of November 15th, there was short interest totalling 263,800 shares, a decrease of 6.3% from the October 31st total of 281,600 shares. Based on an average trading volume of 110,300 shares, the short-interest ratio is presently 2.4 days. Currently, 1.7% of the shares of the company are sold short. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), Walt Disney (DIS), BlackRock (BLK), CVS Health (CVS), Chevron (CVX), Cisco Systems (Csco), Fortinet (FTNT), Abbott Laboratories (ABT) and Boeing (BA).

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (2.61%), Riverbridge Partners LLC (2.34%), Fisher Asset Management LLC (2.15%), Voya Investment Management LLC (1.17%), TimesSquare Capital Management LLC (0.97%) and Eagle Asset Management Inc. (0.81%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., TimesSquare Capital Management LLC, Gamco Investors INC. ET AL, Copeland Capital Management LLC, Russell Investments Group Ltd., Gabelli Funds LLC, Man Group plc and Assenagon Asset Management S.A.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was acquired by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Carillon Tower Advisers Inc., Squarepoint Ops LLC, Teacher Retirement System of Texas, State of Tennessee Treasury Department, First Trust Advisors LP, Voya Investment Management LLC and Voloridge Investment Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $430.09.

How big of a company is Chemed?

Chemed has a market capitalization of $6.89 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

What is Chemed's official website?

The official website for Chemed is http://www.chemed.com/.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  267 (Vote Outperform)
Underperform Votes:  340 (Vote Underperform)
Total Votes:  607
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel